CD8؉ T lymphocytes recognize infected cells that display virus-derived antigenic peptides complexed with major histocompatibility complex class I molecules. Peptides are mainly byproducts of cellular protein turnover by cytosolic proteasomes. Cytosolic tripeptidyl-peptidase II (TPPII) also participates in protein degradation. Several peptidic epitopes unexpectedly do not require proteasomes, but it is unclear which proteases generate them. We studied antigen processing of influenza virus nucleoprotein epitope NP 147-155 , an archetype epitope that is even destroyed by a proteasome-mediated mechanism. TPPII, with the assistance of endoplasmic reticulum trimming metallo-aminopeptidases, probably ERAAP (endoplasmic reticulum aminopeptidase associated with antigen processing), was crucial for nucleoprotein epitope generation both in the presence of functional proteasomes and when blocked by lactacystin, as shown with specific chemical inhibitors and gene silencing. Different protein contexts and subcellular targeting all allowed epitope processing by TPPII as well as trimming. The results show the plasticity of the cell's assortment of proteases for providing ligands for recognition by antiviral CD8 ؉ T cells. Our observations identify for the first time a set of proteases competent for antigen processing of an epitope that is susceptible to destruction by proteasomes.
Viral antigens complexed with major histocompatibility complex (MHC) class I molecules are recognized by cytotoxic T lymphocytes on infected cells. Assays with synthetic peptides identify optimal MHC class I ligands often used for vaccines. However, when natural peptides are analyzed, more complex mixtures including long peptides bulging in the middle of the binding site or with carboxyl extensions are found, reflecting lack of exposure to carboxypeptidases in the antigen processing pathway. In contrast, precursor peptides are exposed to extensive cytosolic aminopeptidase activity, and fewer than 1% survive, only to be further trimmed in the endoplasmic reticulum. We show here a striking example of a nested set of at least three highly antigenic and similarly abundant natural MHC class I ligands, 15, 10, and 9 amino acids in length, derived from a single human immunodeficiency virus gp160 epitope. Antigen processing, thus, gives rise to a rich pool of possible ligands from which MHC class I molecules can choose. The natural peptide set includes a 15-residue-long peptide with unprecedented 6 N-terminal residues that most likely extend out of the MHC class I binding groove. This 15-mer is the longest natural peptide known recognized by cytotoxic T lymphocytes and is surprisingly protected from aminopeptidase trimming in living cells.Newly synthesized viral proteins are proteolytically processed before MHC 4 class I heavy chain- 2 m-peptide complex formation in the lumen of the endoplasmic reticulum (ER) (1). Peptides of 8 -10 residues bind to MHC class I molecules usually by means of two major anchor residues at positions 2 and C-terminal in the antigenic peptide (2, 3). Some peptides may be directly produced by the proteasome in their final form, whereas others are generated as precursor peptides (4). These precursor peptides must display the correct C terminus of the final antigenic peptides, as the evidence suggests the absence of carboxypeptidases in the ER (1, 5). The limited number of studies on extraction and identification of natural peptides derived from a known foreign antigen shows that they constitute complex mixtures, mostly including C-terminal extensions of the minimal epitope (6 -9). On the contrary, peptides are exposed to extensive cytosolic aminopeptidase activity, and fewer than 1% of them survive and are rescued by the transporters associated with antigen processing (TAP) and translocated into the ER (10, 11).In most cases it is assumed that the natural MHC class I ligand is the one that has the canonical anchor sites, the minimal length, and the optimal antigenicity when tested as synthetic peptide. N-terminal extensions of such potential epitopes have been used to study trimming by aminopeptidases purified from the ER or microsomal fractions. There are several reports which show that the two enzymes, mouse endoplasmic reticulum aminopeptidase associated with antigen processing (ERAAP)/human ERAP1 and human leukocyte-derived arginine aminopeptidase (L-RAP)/ERAP2, can indeed trim the precurso...
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Copyright © 2025 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.